GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Taiwan Biomaterial Co 6649.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

35.90

+4.06%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Taiwan Biomaterial Co

Its shares trade on Taipei Exchange under the ticker 6649.TWO. It has been listed since 29 August 2017. In the fiscal year to 31 December 2025, it reported revenue of TWD 220.4m and net income of TWD 58.9m. At that date it held total assets of TWD 789.9m and shareholders' equity of TWD 685.1m.

Taiwan Biomaterial Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical equipment. The company is headquartered in Zhubei, Hsinchu. The company went IPO on 2017-08-29. The products are still in research and development stage. The firm's subsidiary TAIWAN MEDICAL RAPID PROTOTYPING CO., LTD.(TRP) is engaged in trial production of medical equipment. Main products include foam artificial meninges products, stroke thrombus aspiration catheter products, repair and regeneration products for early degenerative arthritis and others.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
29 Aug 2017
Website
twbm.com.tw ↗

Leadership

Pay as last reported

  • Xufu ZongChairman of the Board
  • Maofeng MaGeneral Manager
  • Yunquan LiHead of Finance & Accounting, Corporate Governance Officer, Director
  • Mr. Jiacheng KeDirector
  • Mr. Hongyang LiuDirector
  • Mr. Ming Jen ChanIndependent Director
  • Shunde LaiIndependent Director
  • Banchang YangIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Zhubei, Hsinchu, Taiwan
  • Offers research, development, manufacture, and sale of implantable medical equipment
  • Subsidiary TRP engaged in trial production of medical equipment

Weaknesses

  • Products are still in research and development stage
  • No specific market share or revenue figures provided
  • Limited product information beyond R&D stage

Opportunities

  • Potential growth in health care sector
  • Expansion of R&D into new medical equipment
  • Subsidiary TRP could contribute to product development

Threats

  • Dependence on R&D stage products without commercialization
  • Competition in health care industry
  • Unspecified market risks for R&D stage products

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.